Literature DB >> 17621336

Calibration and precompensation of noncommon path aberrations for extreme adaptive optics.

Jean-François Sauvage1, Thierry Fusco, Gérard Rousset, Cyril Petit.   

Abstract

Noncommon path aberrations (NCPAs) are one of the main limitations of an extreme adaptive optics (AO) system. NCPAs prevent extreme AO systems from achieving their ultimate performance. These static aberrations are unseen by the wavefront sensor and therefore are not corrected in closed loop. We present experimental results validating what we believe to be new procedures of measurement and precompensation of the NCPAs on the AO bench at ONERA (Office National d'Etudes et de Recherches Aérospatiales). The measurement procedure is based on refined algorithms of phase diversity. The precompensation procedure makes use of a pseudo-closed-loop scheme to overcome the AO wavefront-sensor-model uncertainties. Strehl ratio obtained in the images reaches 98.7% at 632.8 nm. This result allows us to be confident of achieving the challenging performance required for direct observation of extrasolar planets.

Year:  2007        PMID: 17621336     DOI: 10.1364/josaa.24.002334

Source DB:  PubMed          Journal:  J Opt Soc Am A Opt Image Sci Vis        ISSN: 1084-7529            Impact factor:   2.129


  3 in total

1.  Non-common path aberration correction in an adaptive optics scanning ophthalmoscope.

Authors:  Yusufu N Sulai; Alfredo Dubra
Journal:  Biomed Opt Express       Date:  2014-08-15       Impact factor: 3.732

2.  Adaptive optics for high-resolution imaging.

Authors:  Karen M Hampson; Raphaël Turcotte; Donald T Miller; Kazuhiro Kurokawa; Jared R Males; Na Ji; Martin J Booth
Journal:  Nat Rev Methods Primers       Date:  2021-10-14

3.  High-accuracy wavefront sensing by phase diversity technique with bisymmetric defocuses diversity phase.

Authors:  Peiguang Zhang; Chengliang Yang; Zihao Xu; Zhaoliang Cao; Quanquan Mu; Li Xuan
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.